Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

ORA SESSIONS 1 - 00

D14 Overcoming Obstacles to Action O Q
Chairs: Elena Borromeo, Allan Ragi
Venue: Session Hall II
Time: 13.00-14.30
103 A national awareness campaign in a country where silence rules 34217
Feliciano Reyna Ganteaume, Venezuela
104 Influencing government policy in Israel: A case study in activism 44257
RommeyA. Hassman* S. Fisher; P. Levy, Israel
105 HIV/AIDS prevention and control through creation of 33256
awareness by motivating and mobilizing religious leaders
Hasan Mahmud*; M.A. Kabir; M.A.H. Mian; M.M. Ali, Bangladesh
106 The Afro-Brazilian religions and the reduction of risk of 14215
HIV-AIDS infection
LuizMott, Brazil
107 HIV-infection impact among North African people living in 34101
France: Actions and survey to promote prevention and better
access to care
Latefa Imane*; F. Joucla; F. Nock; S. Mayou, France
108 The role of appropriate policies in the fight against HIV/AIDS: 34309
Uganda's experiences and the way forward
YusufNsubuga*;John Rwomushana; Elizbeth Madra;
Nathan Bakyaita; Anna Nakaweesi; Jane Francis Asaba Kanyunyuzi;
Fred Odongokara, Uganda

A14 Immune Reconstitution Following ART
Chairs: Mario Clerici, Jan Van Lunzen
Venue: Session Hall III
Time: 15.00-17.00

109 Initiation of antiretroviral therapy during primary HIV
infection is associated with rapid stabilization of the TCR Vb
repertoire and reduction of CD8+ T cell oligoclonality
Hugo Soudeyns*; G. Campi; A. Lazzarin; A.S. Fauci; L. Corey;
G. Casorati; G. Pantaleo, Switzerland
110 Down regulation of CD8+ T cell expansions in HIV patients
receiving highly active combination therapy
Guy Gorochov*; U.N. Neuman; C. Parizot; T. Li; B. Autran;
P. Debre, France
111 Specific T-cell responses in HIV-infected patients after highly
active antiretroviral treatment (HAART)
Ann-Charlotte Leandersson*; G. Bratt; M. Fredriksson;
J. Hinkula; E. Sandstrom; B. Wahren, Sweden
112 Prolonged suppression of HIV-1 viremia results in profound
but incomplete enhancement of anti-HIV-1 CTL responses

31121

31165
31142
31124

in advanced infection
Charles Rinaldo*;X.L. Huang; Z. Fan;J. Liebmann; D. McMahon;
S. Riddler;J. Mellors, USA
113 Functional lymphocyte reconstitution and HIV-1 specific 31134
T cell responses during highly active antiretroviral therapy (HAART)
Oscar Pontesilli*; S. Kerkhof-Garde; N.G. Pakker; D. W. Notermans;
M.T.L. Roos; S.A. Danner; F. Miedema, The Netherlands
114 Immune reconstitution and role of thymus during potent 12247
antiretroviral therapy in vertically HIV-infected children
Allessandra Vigano*; M. Clerici; D. Bricalli; M. Saresella;
S. Difabio; N. Principi; S. Vella, Italy
115 Improved cellular immunity in acute HIV-1 infection 31177
following antiretroviral therapy
Julie McElrath*; U. Malhotra; L. Musey; M. Berry;
Y. Huang; L. Corey, USA
116 Expression of CD28 and CD38 by CD8+ T cells in HIV-infection 31170
correlates with viral load and CD4+ T cell number at baseline
and during treatment
Philippe Burgisser; C. Hammann; D. Kaufmann; P.C. Frei,
Switzerland
A15 Early Events in HIV Cycle
Chairs: George Pavlakis, Kenneth L. Rosenthal
Venue: Session Hall IV
Time: 15.00-17.00
117 Chemokines and chemokine receptors in HIV-infection
Paolo Lusso
118 HIV co-receptors
Ed Berger
119 Nuclear transport and pre-integration complex
Mario Stevenson
120 The HIV nucleocapsid protein as a molecular chaperone and
drug target in the viral life cycle
Jean-Luc Darlix

NOTES

Pathway Symbols: 0 Human Rights Policy

CONFERENCE WORKBOOK

15